We found no significant difference between sapropterin ( n = @ ) and placebo ( n = @ ) in the primary end point ( mean difference in reactive hyperemia index by peripheral arterial tonometry changes @ -LSB- @ % confidence interval , -@ , @ -RSB- ) .